The Human Stem Cells Institute's net profit under RAS for 9 months of 2020 was ₽32.632 million, down 4.4 times from ₽145.903 million in the previous year. Revenues dropped 18.3% to ₽42.459 million, down from ₽51.967 million a year earlier.
The Human Stem Cells Institute's net profit under RAS for 9 months of 2020 was ₽32.632 million, down 4.4 times from ₽145.903 million in the previous year. Revenues dropped 18.3% to ₽42.459 million, down from ₽51.967 million a year earlier. 
e-disclosure.ru
English (US) 